Tyra Biosciences Investor Relations Material
Latest events
Study Update
Tyra Biosciences
Q1 2025
8 May, 2025
Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyra Biosciences Inc
Access all reports
Tyra Biosciences Inc. is a clinical-stage biotechnology company specializing in the development of precision medicines targeted at Fibroblast Growth Factor Receptor biology. Leveraging its proprietary platform, Tyra Biosciences focuses on creating drugs through iterative molecular snapshots which aid in predicting genetic alterations and developing therapies for oncology and genetically defined conditions. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
TYRA
Country
🇺🇸 United States